(148 days)
Not Found
No
The summary describes a mechanical catheter for drug delivery and explicitly states that AI/ML is "Not Found".
Yes
The device is intended for the administration of local anesthetic agents to provide continuous epidural or caudal anesthesia, which is a therapeutic intervention to manage pain.
No
The device is described as a catheter for administering anesthetic agents, not for diagnosing conditions.
No
The device description clearly states it is a catheter, which is a physical medical device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the administration of local anesthetic agents into the epidural space for continuous epidural or caudal anesthesia. This is a therapeutic procedure performed directly on a patient, not a test performed on a sample taken from a patient to diagnose a condition.
- Device Description: The description focuses on the physical characteristics and materials of a catheter used for drug delivery.
- Lack of IVD Indicators: There is no mention of analyzing samples (blood, urine, tissue, etc.), detecting biomarkers, or providing diagnostic information.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device's function is to deliver medication, which is a therapeutic action, not a diagnostic one.
N/A
Intended Use / Indications for Use
The Spring-Wound Epidiral Catheter is intended for administration of local anesthetic agents into the epidural space to provide continuous epidural or caudal anesthesia. Micor recommends that the catheter be removed or replaced every 72 hours.
Product codes
73 BSO
Device Description
This catheter exhibits the same design and performance as the Sumotor Shinned predicates. Its external sheath (patient-contact) material is identical to that used in the Preferred Medical predicate.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
epidural space
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5120 Anesthesia conduction catheter.
(a)
Identification. An anesthesia conduction catheter is a flexible tubular device used to inject local anesthetics into a patient and to provide continuous regional anesthesia.(b)
Classification. Class II (performance standards).
0
OCT 28 1999
Summary of Safety and Effectiveness
Micor®, Inc. Spring-Wound Epidural Catheter
Micor Contact 1.0
Charles W. Eslep Vice President Micor, Inc. 2855 Oxford Boulevard Allison Park, Pennsylvania 15101 Telephone: (412)487-1113 (412)487-1747 Facsimile:
Device Name 2.0
Trade Name 2.1
Spring-Wound Epidural Catheter
2.2 Classification Name
| Device Name: | Catheter, Conduction, Anesthetic |
|---|---|
| Speciality: | Anesthesiology |
| Product Code: | 73 BSO |
| Device Class: | 2 |
| Regulation No.: | 21 CFR 868.5120 |
3.0 Predicate Device
- Arrow International, Inc. FlexTip Plus® Epidural Catheter 3.1
- Epimed International, Inc. Feth-R-Kath® Epidural Catheters (K981329) 3.2
- Preferred Medical Products Epidural Catheter (K885278) 3.3
Product Description/Function 4.0
- Description This catheter exhibits the same design and performance 4.1 Desemption Trilo Sumotor Shinned predicates. Its external sheath (patient-contact) material is identical to that used in the Preferred Medical predicate.
- Function The subject device will function the same as the predicate 4.2 devices.
1
Comparison of the Subject Device and Predicate Devices for Equivalence 5.0
- General Catheters incorporating an internal spiral-wound spring, and 5.1 being used for the delivery of anesthetic agents, have been on the U.S. market for over 10 years. These include catheters built and legallymarketed by Arrow International and Epimed International.
- Technological Characteristics The technological characteristics of 5.2 Micor's Spring-Wound Epidural Catheter, as compared to those of the Arrow and Epimed predicates, are essentially the same.
- 5.3 Materials The materials incorporated in the subject device are identical to ones contained in the legally-marketed predicates, Arrow's FlexTip Plus, Epimed's Feth-R-Cath, and Preferred Medical's epidural catheter.
- 5.4 Intended Use The intended use of the subject device is equivalent to that of all three predicate devices.
- Conclusion No new issues of safety or effectiveness are raised by the 5.5 design of this device. Micor's Spring-Wound Epidural Catheter is equivalent to the cited predicate devices in its material, technology, and intended use.
2
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle with three stripes representing the department's mission. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circle around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 2 8 1999
Mr. Charles W. Eslep Micor, Inc. 2855 Oxford Boulevard Allison Park, PA 15101
Re : K991879 Micor Spring Wound Catheter (part# CS **-0217) Regulatory Class: II (twc) ... . . : Product Code: 73 BSO Dated: September 23, 1999 Received: September 28, 1999
Dear Mr. Eslep:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Mr. Charles W. Eslep
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
feanor AU Westerhausen
Wolf Sapirstein, M.D. Acting Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE STATEMENT
K99/87 9
510(k) Number (if known)
Spring-Wound Epidural Catheter Device Name
Indications for Use:
The Spring-Wound Epidiral Catheter is intended for administration of local anesthetic agents into the epidural space to provide continuous epidural or caudal anesthesia. Micor recommends that the catheter be removed or replaced every 72 hours.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED.
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Cardiovascular, Respiratory,
and Neurological Devices
510(k) Number K991879
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter__